Published December 2024 | Version v2
Journal article

Development of single-vial kit for simple and convenient formulation of 68Ga-NODAGA-JR11: PET agent for diagnosis of neuroendocrine tumor

  • 1. Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India

Description

68Ga-NODAGA-JR11 has emerged as a promising somatostatin antagonist for PET-imaging of neuroendocrine tumors. Preliminary success of the agent necessitates further multicentric clinical trials for complete evaluation in human cancer patients. Single-step formulation of 68Ga-NODAGA-JR11 at hospital radiopharmacy shall encourage increased participation of hospitals facilitating multi-centre trials. Thus, freeze-dried kits were developed for convenient formulation of 68Ga-NODAGA-JR11 and preliminary clinical studies were performed in neuroendocrine cancer patients. Kit formulated 68Ga-NODAGA-JR11 exhibited high uptake in primary as well as metastatic lesions.

Additional details

Publishing Information

Journal Title
BARC Newsletter
Journal Page Range
13-15
ISSN
0976-2108